Systematic Literature Review on Buprenorphine/naloxone Use in Outpatient Opioid Dependence Treatment

被引:0
|
作者
Main, Fiona [1 ]
Kelly, Len
机构
[1] Northern Ontario Sch Med, Family Med, Sudbury, ON, Canada
关键词
addiction; opioid substitution therapy; buprenorphine/naloxone; outpatient;
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: Summarize the literature on buprenorphine/ naloxone for outpatient treatment of opioid dependence disorder. Methods: a literature of EMBASE and Medline 2000-2014 using the terms "naloxone + buprenorphine" and "opioid-related disorders". Results: Over two hundred articles were retrieved. Seventeen studies were ultimately selected and reviewed for study quality, using Downs and Black's 1998 checklist, the Canadian Task Force on Preventive Health Care levels of evidence and study outcome analysis. Conclusion: Buprenorphine/naloxone appears to be a safe, effective treatment modality for treatment of opioid dependence. As a recently introduced medication in North America, clinicians are slow to fully embrace it use. It provides an opportunity to more widely provide opioid substitution therapy in primary care settings.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [21] Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
    Onuoha, Erica N.
    Leff, Jared A.
    Schackman, Bruce R.
    McCollister, Kathryn E.
    Polsky, Daniel
    Murphy, Sean M.
    VALUE IN HEALTH, 2021, 24 (07) : 1068 - 1083
  • [22] Incidence of buprenorphine-precipitated opioid withdrawal in adults with opioid use disorder: A systematic review
    Gregory, Caroline
    Yadav, Krishan
    Linders, Jordyn
    Sikora, Lindsey
    Eagles, Debra
    ADDICTION, 2025, 120 (01) : 7 - 20
  • [23] Illicit Use of Buprenorphine/Naloxone Among Injecting and Noninjecting Opioid Users
    Bazazi, Alexander R.
    Yokell, Michael
    Fu, Jeannia J.
    Rich, Josiah D.
    Zaller, Nickolas D.
    JOURNAL OF ADDICTION MEDICINE, 2011, 5 (03) : 175 - 180
  • [24] Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial
    Webster, Lynn
    Hjelmstrom, Peter
    Sumner, Michael
    Gunderson, Erik W.
    JOURNAL OF ADDICTIVE DISEASES, 2016, 35 (04) : 325 - 338
  • [25] Illicit use and diversion of buprenorphine/naloxone among patients in buprenorphine/naloxone maintenance treatment in Istanbul, Turkey
    Evren, Cuneyt
    Bozkurt, Muge
    Cetin, Turan
    Karabulut, Vahap
    Evren, Bilge
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2014, 16 (01) : 25 - 34
  • [26] Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence
    Poole, Sabrina A.
    Pecoraro, Anna
    Subramaniam, Geetha
    Woody, George
    Vetter, Victoria L.
    JOURNAL OF ADDICTION MEDICINE, 2016, 10 (01) : 26 - 33
  • [27] Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders
    Hammond, Christopher J.
    Park, Grace
    Kady, Annabel
    Rathod, Krutika
    Rahman, Naisa
    Vidal, Carol
    Wenzel, Kevin
    Fishman, Marc
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 133
  • [28] Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro-dosing - a case series
    Brar, Rupinder
    Fairbairn, Nadia
    Sutherland, Christy
    Nolan, Seonaid
    DRUG AND ALCOHOL REVIEW, 2020, 39 (05) : 588 - 594
  • [29] Buprenorphine: a controlled clinical trial in the treatment of opioid dependence
    Pani, PP
    Maremmani, I
    Pirastu, R
    Tagliamonte, A
    Gessa, GL
    DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (01) : 39 - 50
  • [30] Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review
    Shirk, Steven D.
    Ameral, Victoria
    Kraus, Shane W.
    Houchins, Joseph
    Kelly, Megan
    Pugh, Kendra
    Reilly, Erin
    Desai, Nitigna
    JOURNAL OF DUAL DIAGNOSIS, 2021, 17 (03) : 207 - 215